The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis.
Yunzhi ZouDepei LiJiayu GuSiyu ChenXia WenJiajun DongXiaobing JiangPublished in: BMC endocrine disorders (2021)
Registration number CRD42021245888 (PROSPERO).